Skip to main content

Table 1 Headache relief (HR) and therapeutic gain (percentage HR after subcutaneous sumatriptan 6 mg minus percentage HR after effervescent aspirin 1,000 mg plus metoclopramide) for the first-treated migraine attack

From: Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial

 

Sumatriptan (n = 122)

ASP + M (n = 125)

Headache relief after 30 min

  

 Yes

62 (50%)

31 (24%)

 No

62 (50%)

96 (76%)

Therapeutic gain 26% (95% CI 14–37%)

Headache relief after 60 min

 Yes

87 (71%)

57 (45%)

 No

35 (29%)

69 (55%)

Therapeutic gain 26% (95% CI 14–38%)

Headache relief after 120 min

 Yes

99 (84%)

79 (62%)

 No

19 (16%)

48 (38%)

Therapeutic gain 22% (95% CI 11–32%)